ArticleVaccine2024

Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18-64 years of age.

Mary Patricia Nowalk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.